CareCloud, Inc.
CareCloud, Inc. CCLDP Peers
See (CCLDP) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CCLDP | $19.43 | -1.87% | 566.58M | N/A | N/A | N/A |
| VEEV | $240.28 | -0.38% | 39.15B | 55.62 | $4.32 | N/A |
| GEHC | $72.84 | -1.34% | 33.35B | 15.30 | $4.76 | +0.18% |
| GEHCV | $56.00 | -4.08% | 25.46B | N/A | N/A | +0.18% |
| DOCS | $59.51 | -1.53% | 11.17B | 59.51 | $1.00 | N/A |
| SGFY | $30.49 | +0.07% | 8.93B | 70.91 | $0.43 | N/A |
| HQY | $98.06 | +1.10% | 8.48B | 89.96 | $1.09 | N/A |
| RCM | $14.31 | N/A | 6.04B | -102.21 | -$0.14 | N/A |
| BTSG | $23.49 | +1.08% | 4.09B | 87.00 | $0.27 | N/A |
| BTSGU | $82.03 | +0.64% | 4.02B | N/A | N/A | N/A |
Stock Comparison
CCLDP vs VEEV Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, VEEV has a market cap of 39.15B. Regarding current trading prices, CCLDP is priced at $19.43, while VEEV trades at $240.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas VEEV's P/E ratio is 55.62. In terms of profitability, CCLDP's ROE is +0.21%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, CCLDP is less volatile compared to VEEV. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs GEHC Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, GEHC has a market cap of 33.35B. Regarding current trading prices, CCLDP is priced at $19.43, while GEHC trades at $72.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas GEHC's P/E ratio is 15.30. In terms of profitability, CCLDP's ROE is +0.21%, compared to GEHC's ROE of +0.26%. Regarding short-term risk, CCLDP is less volatile compared to GEHC. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs GEHCV Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, GEHCV has a market cap of 25.46B. Regarding current trading prices, CCLDP is priced at $19.43, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas GEHCV's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to GEHCV's ROE of +0.26%. Regarding short-term risk, CCLDP is less volatile compared to GEHCV. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs DOCS Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, DOCS has a market cap of 11.17B. Regarding current trading prices, CCLDP is priced at $19.43, while DOCS trades at $59.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 59.51. In terms of profitability, CCLDP's ROE is +0.21%, compared to DOCS's ROE of +0.21%. Regarding short-term risk, CCLDP is less volatile compared to DOCS. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs SGFY Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SGFY has a market cap of 8.93B. Regarding current trading prices, CCLDP is priced at $19.43, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, CCLDP's ROE is +0.21%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, CCLDP is less volatile compared to SGFY. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs HQY Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, HQY has a market cap of 8.48B. Regarding current trading prices, CCLDP is priced at $19.43, while HQY trades at $98.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 89.96. In terms of profitability, CCLDP's ROE is +0.21%, compared to HQY's ROE of +0.05%. Regarding short-term risk, CCLDP is less volatile compared to HQY. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs RCM Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, RCM has a market cap of 6.04B. Regarding current trading prices, CCLDP is priced at $19.43, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, CCLDP's ROE is +0.21%, compared to RCM's ROE of -0.02%. Regarding short-term risk, CCLDP and RCM have similar daily volatility (0.00).
CCLDP vs BTSG Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, BTSG has a market cap of 4.09B. Regarding current trading prices, CCLDP is priced at $19.43, while BTSG trades at $23.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 87.00. In terms of profitability, CCLDP's ROE is +0.21%, compared to BTSG's ROE of +0.03%. Regarding short-term risk, CCLDP is less volatile compared to BTSG. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs BTSGU Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, BTSGU has a market cap of 4.02B. Regarding current trading prices, CCLDP is priced at $19.43, while BTSGU trades at $82.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas BTSGU's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to BTSGU's ROE of +0.03%. Regarding short-term risk, CCLDP is less volatile compared to BTSGU. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs ONEM Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, ONEM has a market cap of 3.40B. Regarding current trading prices, CCLDP is priced at $19.43, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, CCLDP's ROE is +0.21%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, CCLDP is less volatile compared to ONEM. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs PRVA Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, PRVA has a market cap of 2.96B. Regarding current trading prices, CCLDP is priced at $19.43, while PRVA trades at $24.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 202.41. In terms of profitability, CCLDP's ROE is +0.21%, compared to PRVA's ROE of +0.02%. Regarding short-term risk, CCLDP is less volatile compared to PRVA. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs CERT Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, CERT has a market cap of 1.90B. Regarding current trading prices, CCLDP is priced at $19.43, while CERT trades at $11.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas CERT's P/E ratio is -586.00. In terms of profitability, CCLDP's ROE is +0.21%, compared to CERT's ROE of -0.00%. Regarding short-term risk, CCLDP is less volatile compared to CERT. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs PGNY Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, PGNY has a market cap of 1.87B. Regarding current trading prices, CCLDP is priced at $19.43, while PGNY trades at $21.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas PGNY's P/E ratio is 38.35. In terms of profitability, CCLDP's ROE is +0.21%, compared to PGNY's ROE of +0.12%. Regarding short-term risk, CCLDP is less volatile compared to PGNY. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs PINC Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, PINC has a market cap of 1.85B. Regarding current trading prices, CCLDP is priced at $19.43, while PINC trades at $22.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas PINC's P/E ratio is 22.08. In terms of profitability, CCLDP's ROE is +0.21%, compared to PINC's ROE of +0.03%. Regarding short-term risk, CCLDP is less volatile compared to PINC. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs SDGR Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SDGR has a market cap of 1.76B. Regarding current trading prices, CCLDP is priced at $19.43, while SDGR trades at $23.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SDGR's P/E ratio is -9.10. In terms of profitability, CCLDP's ROE is +0.21%, compared to SDGR's ROE of -0.45%. Regarding short-term risk, CCLDP is less volatile compared to SDGR. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs WGS Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, WGS has a market cap of 1.70B. Regarding current trading prices, CCLDP is priced at $19.43, while WGS trades at $59.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas WGS's P/E ratio is -42.77. In terms of profitability, CCLDP's ROE is +0.21%, compared to WGS's ROE of -0.17%. Regarding short-term risk, CCLDP is less volatile compared to WGS. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs NXGN Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, NXGN has a market cap of 1.61B. Regarding current trading prices, CCLDP is priced at $19.43, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, CCLDP's ROE is +0.21%, compared to NXGN's ROE of +0.03%. Regarding short-term risk, CCLDP is less volatile compared to NXGN. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs PHR Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, PHR has a market cap of 1.54B. Regarding current trading prices, CCLDP is priced at $19.43, while PHR trades at $26.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas PHR's P/E ratio is -25.63. In terms of profitability, CCLDP's ROE is +0.21%, compared to PHR's ROE of -0.23%. Regarding short-term risk, CCLDP is less volatile compared to PHR. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs GDRX Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, GDRX has a market cap of 1.53B. Regarding current trading prices, CCLDP is priced at $19.43, while GDRX trades at $4.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 61.00. In terms of profitability, CCLDP's ROE is +0.21%, compared to GDRX's ROE of +0.07%. Regarding short-term risk, CCLDP is less volatile compared to GDRX. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs AGTI Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, AGTI has a market cap of 1.37B. Regarding current trading prices, CCLDP is priced at $19.43, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, CCLDP's ROE is +0.21%, compared to AGTI's ROE of -0.03%. Regarding short-term risk, CCLDP is less volatile compared to AGTI. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs OMCL Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, OMCL has a market cap of 1.35B. Regarding current trading prices, CCLDP is priced at $19.43, while OMCL trades at $28.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas OMCL's P/E ratio is 62.46. In terms of profitability, CCLDP's ROE is +0.21%, compared to OMCL's ROE of +0.02%. Regarding short-term risk, CCLDP is less volatile compared to OMCL. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs TDOC Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, TDOC has a market cap of 1.29B. Regarding current trading prices, CCLDP is priced at $19.43, while TDOC trades at $7.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -1.24. In terms of profitability, CCLDP's ROE is +0.21%, compared to TDOC's ROE of -0.68%. Regarding short-term risk, CCLDP is less volatile compared to TDOC. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs TXG Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, TXG has a market cap of 1.14B. Regarding current trading prices, CCLDP is priced at $19.43, while TXG trades at $9.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas TXG's P/E ratio is -7.02. In terms of profitability, CCLDP's ROE is +0.21%, compared to TXG's ROE of -0.22%. Regarding short-term risk, CCLDP is less volatile compared to TXG. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs EVH Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, EVH has a market cap of 1.05B. Regarding current trading prices, CCLDP is priced at $19.43, while EVH trades at $8.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas EVH's P/E ratio is -7.32. In terms of profitability, CCLDP's ROE is +0.21%, compared to EVH's ROE of -0.11%. Regarding short-term risk, CCLDP is less volatile compared to EVH. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs NUTX Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, NUTX has a market cap of 877.92M. Regarding current trading prices, CCLDP is priced at $19.43, while NUTX trades at $158.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas NUTX's P/E ratio is 16.35. In terms of profitability, CCLDP's ROE is +0.21%, compared to NUTX's ROE of +0.63%. Regarding short-term risk, CCLDP is less volatile compared to NUTX. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs HSTM Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, HSTM has a market cap of 826.63M. Regarding current trading prices, CCLDP is priced at $19.43, while HSTM trades at $27.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 42.98. In terms of profitability, CCLDP's ROE is +0.21%, compared to HSTM's ROE of +0.05%. Regarding short-term risk, CCLDP is less volatile compared to HSTM. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs SLP Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SLP has a market cap of 647.57M. Regarding current trading prices, CCLDP is priced at $19.43, while SLP trades at $32.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SLP's P/E ratio is 89.44. In terms of profitability, CCLDP's ROE is +0.21%, compared to SLP's ROE of +0.04%. Regarding short-term risk, CCLDP is less volatile compared to SLP. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs MPLN-WT Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, MPLN-WT has a market cap of 625.23M. Regarding current trading prices, CCLDP is priced at $19.43, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to MPLN-WT's ROE of -5.18%. Regarding short-term risk, CCLDP is less volatile compared to MPLN-WT. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs ACCD Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, ACCD has a market cap of 575.59M. Regarding current trading prices, CCLDP is priced at $19.43, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, CCLDP's ROE is +0.21%, compared to ACCD's ROE of -0.45%. Regarding short-term risk, CCLDP and ACCD have similar daily volatility (0.00).
CCLDP vs SHCR Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SHCR has a market cap of 531.78M. Regarding current trading prices, CCLDP is priced at $19.43, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, CCLDP's ROE is +0.21%, compared to SHCR's ROE of -0.29%. Regarding short-term risk, CCLDP is less volatile compared to SHCR. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs CTEV Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, CTEV has a market cap of 441.48M. Regarding current trading prices, CCLDP is priced at $19.43, while CTEV trades at $26.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -0.32. In terms of profitability, CCLDP's ROE is +0.21%, compared to CTEV's ROE of N/A. Regarding short-term risk, CCLDP is less volatile compared to CTEV. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs SLGC Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SLGC has a market cap of 396.23M. Regarding current trading prices, CCLDP is priced at $19.43, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, CCLDP's ROE is +0.21%, compared to SLGC's ROE of -0.09%. Regarding short-term risk, CCLDP is less volatile compared to SLGC. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs SLGCW Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SLGCW has a market cap of 396.23M. Regarding current trading prices, CCLDP is priced at $19.43, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, CCLDP's ROE is +0.21%, compared to SLGCW's ROE of -0.09%. Regarding short-term risk, CCLDP is less volatile compared to SLGCW. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs MPLN Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, MPLN has a market cap of 374.98M. Regarding current trading prices, CCLDP is priced at $19.43, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, CCLDP's ROE is +0.21%, compared to MPLN's ROE of -5.18%. Regarding short-term risk, CCLDP is less volatile compared to MPLN. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs TBRG Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, TBRG has a market cap of 371.83M. Regarding current trading prices, CCLDP is priced at $19.43, while TBRG trades at $24.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is -20.29. In terms of profitability, CCLDP's ROE is +0.21%, compared to TBRG's ROE of -0.10%. Regarding short-term risk, CCLDP is less volatile compared to TBRG. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs DH Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, DH has a market cap of 366.04M. Regarding current trading prices, CCLDP is priced at $19.43, while DH trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas DH's P/E ratio is -0.77. In terms of profitability, CCLDP's ROE is +0.21%, compared to DH's ROE of -1.07%. Regarding short-term risk, CCLDP is less volatile compared to DH. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs SPOK Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SPOK has a market cap of 335.53M. Regarding current trading prices, CCLDP is priced at $19.43, while SPOK trades at $16.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 21.18. In terms of profitability, CCLDP's ROE is +0.21%, compared to SPOK's ROE of +0.10%. Regarding short-term risk, CCLDP is less volatile compared to SPOK. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs NRC Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, NRC has a market cap of 305.10M. Regarding current trading prices, CCLDP is priced at $19.43, while NRC trades at $13.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 13.13. In terms of profitability, CCLDP's ROE is +0.21%, compared to NRC's ROE of +0.71%. Regarding short-term risk, CCLDP is less volatile compared to NRC. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs HCAT Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, HCAT has a market cap of 290.93M. Regarding current trading prices, CCLDP is priced at $19.43, while HCAT trades at $4.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is -3.63. In terms of profitability, CCLDP's ROE is +0.21%, compared to HCAT's ROE of -0.20%. Regarding short-term risk, CCLDP is less volatile compared to HCAT. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs TRHC Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, TRHC has a market cap of 284.03M. Regarding current trading prices, CCLDP is priced at $19.43, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, CCLDP's ROE is +0.21%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, CCLDP is less volatile compared to TRHC. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs SMFR Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SMFR has a market cap of 246.37M. Regarding current trading prices, CCLDP is priced at $19.43, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SMFR's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to SMFR's ROE of -0.17%. Regarding short-term risk, CCLDP is less volatile compared to SMFR. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs SOPH Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SOPH has a market cap of 205.17M. Regarding current trading prices, CCLDP is priced at $19.43, while SOPH trades at $3.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -3.07. In terms of profitability, CCLDP's ROE is +0.21%, compared to SOPH's ROE of -0.63%. Regarding short-term risk, CCLDP is less volatile compared to SOPH. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs OPRX Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, OPRX has a market cap of 186.97M. Regarding current trading prices, CCLDP is priced at $19.43, while OPRX trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is -9.19. In terms of profitability, CCLDP's ROE is +0.21%, compared to OPRX's ROE of -0.13%. Regarding short-term risk, CCLDP is less volatile compared to OPRX. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs EUDA Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, EUDA has a market cap of 146.40M. Regarding current trading prices, CCLDP is priced at $19.43, while EUDA trades at $3.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas EUDA's P/E ratio is -7.30. In terms of profitability, CCLDP's ROE is +0.21%, compared to EUDA's ROE of +3.05%. Regarding short-term risk, CCLDP is less volatile compared to EUDA. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs CPSI Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, CPSI has a market cap of 133.71M. Regarding current trading prices, CCLDP is priced at $19.43, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, CCLDP's ROE is +0.21%, compared to CPSI's ROE of -0.03%. Regarding short-term risk, CCLDP is less volatile compared to CPSI. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs AUGX Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, AUGX has a market cap of 115.91M. Regarding current trading prices, CCLDP is priced at $19.43, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, CCLDP's ROE is +0.21%, compared to AUGX's ROE of -1.82%. Regarding short-term risk, CCLDP is less volatile compared to AUGX. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs AMWL Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, AMWL has a market cap of 112.80M. Regarding current trading prices, CCLDP is priced at $19.43, while AMWL trades at $7.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -0.70. In terms of profitability, CCLDP's ROE is +0.21%, compared to AMWL's ROE of -0.48%. Regarding short-term risk, CCLDP is less volatile compared to AMWL. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs SY Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SY has a market cap of 108.65M. Regarding current trading prices, CCLDP is priced at $19.43, while SY trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SY's P/E ratio is -1.05. In terms of profitability, CCLDP's ROE is +0.21%, compared to SY's ROE of -0.26%. Regarding short-term risk, CCLDP is less volatile compared to SY. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs CCLD Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, CCLD has a market cap of 85.91M. Regarding current trading prices, CCLDP is priced at $19.43, while CCLD trades at $2.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is -9.67. In terms of profitability, CCLDP's ROE is +0.21%, compared to CCLD's ROE of +0.21%. Regarding short-term risk, CCLDP is less volatile compared to CCLD. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs CCLDO Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, CCLDO has a market cap of 83.80M. Regarding current trading prices, CCLDP is priced at $19.43, while CCLDO trades at $19.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to CCLDO's ROE of +0.21%. Regarding short-term risk, CCLDP is less volatile compared to CCLDO. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs FORA Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, FORA has a market cap of 58.02M. Regarding current trading prices, CCLDP is priced at $19.43, while FORA trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -15.50. In terms of profitability, CCLDP's ROE is +0.21%, compared to FORA's ROE of -0.14%. Regarding short-term risk, CCLDP is less volatile compared to FORA. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs BEATW Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, BEATW has a market cap of 58.01M. Regarding current trading prices, CCLDP is priced at $19.43, while BEATW trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas BEATW's P/E ratio is -1.02. In terms of profitability, CCLDP's ROE is +0.21%, compared to BEATW's ROE of -2.81%. Regarding short-term risk, CCLDP is less volatile compared to BEATW. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs BEAT Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, BEAT has a market cap of 53.96M. Regarding current trading prices, CCLDP is priced at $19.43, while BEAT trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas BEAT's P/E ratio is -2.19. In terms of profitability, CCLDP's ROE is +0.21%, compared to BEAT's ROE of -2.81%. Regarding short-term risk, CCLDP is less volatile compared to BEAT. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs SHLT Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SHLT has a market cap of 41.56M. Regarding current trading prices, CCLDP is priced at $19.43, while SHLT trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -4.68. In terms of profitability, CCLDP's ROE is +0.21%, compared to SHLT's ROE of -0.09%. Regarding short-term risk, CCLDP is less volatile compared to SHLT. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs SNCE Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SNCE has a market cap of 34.66M. Regarding current trading prices, CCLDP is priced at $19.43, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, CCLDP's ROE is +0.21%, compared to SNCE's ROE of -0.59%. Regarding short-term risk, CCLDP is less volatile compared to SNCE. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs AKLI Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, AKLI has a market cap of 34.10M. Regarding current trading prices, CCLDP is priced at $19.43, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, CCLDP's ROE is +0.21%, compared to AKLI's ROE of -0.74%. Regarding short-term risk, CCLDP is less volatile compared to AKLI. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs SHCRW Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SHCRW has a market cap of 32.55M. Regarding current trading prices, CCLDP is priced at $19.43, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, CCLDP's ROE is +0.21%, compared to SHCRW's ROE of -0.29%. Regarding short-term risk, CCLDP is less volatile compared to SHCRW. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs RNLX Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, RNLX has a market cap of 22.55M. Regarding current trading prices, CCLDP is priced at $19.43, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, CCLDP's ROE is +0.21%, compared to RNLX's ROE of +2.93%. Regarding short-term risk, CCLDP is less volatile compared to RNLX. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs LIFW Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, LIFW has a market cap of 22.36M. Regarding current trading prices, CCLDP is priced at $19.43, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, CCLDP's ROE is +0.21%, compared to LIFW's ROE of -1.56%. Regarding short-term risk, CCLDP and LIFW have similar daily volatility (0.00).
CCLDP vs VSEEW Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, VSEEW has a market cap of 19.92M. Regarding current trading prices, CCLDP is priced at $19.43, while VSEEW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to VSEEW's ROE of -6.10%. Regarding short-term risk, CCLDP is less volatile compared to VSEEW. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs MSPR Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, MSPR has a market cap of 17.83M. Regarding current trading prices, CCLDP is priced at $19.43, while MSPR trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas MSPR's P/E ratio is -0.01. In terms of profitability, CCLDP's ROE is +0.21%, compared to MSPR's ROE of -1.56%. Regarding short-term risk, CCLDP is less volatile compared to MSPR. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs VSEE Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, VSEE has a market cap of 17.23M. Regarding current trading prices, CCLDP is priced at $19.43, while VSEE trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -13.75. In terms of profitability, CCLDP's ROE is +0.21%, compared to VSEE's ROE of -6.10%. Regarding short-term risk, CCLDP is less volatile compared to VSEE. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs BFRG Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, BFRG has a market cap of 16.62M. Regarding current trading prices, CCLDP is priced at $19.43, while BFRG trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -2.08. In terms of profitability, CCLDP's ROE is +0.21%, compared to BFRG's ROE of -1.33%. Regarding short-term risk, CCLDP is less volatile compared to BFRG. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs ONMD Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, ONMD has a market cap of 14.40M. Regarding current trading prices, CCLDP is priced at $19.43, while ONMD trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -1.30. In terms of profitability, CCLDP's ROE is +0.21%, compared to ONMD's ROE of +0.62%. Regarding short-term risk, CCLDP is less volatile compared to ONMD. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs BBLN Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, BBLN has a market cap of 14.10M. Regarding current trading prices, CCLDP is priced at $19.43, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, CCLDP's ROE is +0.21%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, CCLDP is less volatile compared to BBLN. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs INOV Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, INOV has a market cap of 13.84M. Regarding current trading prices, CCLDP is priced at $19.43, while INOV trades at $31.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas INOV's P/E ratio is 16.39. In terms of profitability, CCLDP's ROE is +0.21%, compared to INOV's ROE of +0.03%. Regarding short-term risk, CCLDP is less volatile compared to INOV. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs SCNX Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, SCNX has a market cap of 11.92M. Regarding current trading prices, CCLDP is priced at $19.43, while SCNX trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas SCNX's P/E ratio is -0.17. In terms of profitability, CCLDP's ROE is +0.21%, compared to SCNX's ROE of +0.19%. Regarding short-term risk, CCLDP is less volatile compared to SCNX. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs STRM Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, STRM has a market cap of 11.22M. Regarding current trading prices, CCLDP is priced at $19.43, while STRM trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -1.02. In terms of profitability, CCLDP's ROE is +0.21%, compared to STRM's ROE of -0.80%. Regarding short-term risk, CCLDP is less volatile compared to STRM. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs HCTI Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, HCTI has a market cap of 10.17M. Regarding current trading prices, CCLDP is priced at $19.43, while HCTI trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.20. In terms of profitability, CCLDP's ROE is +0.21%, compared to HCTI's ROE of +2.95%. Regarding short-term risk, CCLDP is less volatile compared to HCTI. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs ETAO Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, ETAO has a market cap of 9.78M. Regarding current trading prices, CCLDP is priced at $19.43, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, CCLDP's ROE is +0.21%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, CCLDP is less volatile compared to ETAO. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs MGRX Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, MGRX has a market cap of 9.78M. Regarding current trading prices, CCLDP is priced at $19.43, while MGRX trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.32. In terms of profitability, CCLDP's ROE is +0.21%, compared to MGRX's ROE of -0.87%. Regarding short-term risk, CCLDP is less volatile compared to MGRX. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs OTRK Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, OTRK has a market cap of 7.27M. Regarding current trading prices, CCLDP is priced at $19.43, while OTRK trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.10. In terms of profitability, CCLDP's ROE is +0.21%, compared to OTRK's ROE of -1.76%. Regarding short-term risk, CCLDP is less volatile compared to OTRK. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs HLTH Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, HLTH has a market cap of 6.90M. Regarding current trading prices, CCLDP is priced at $19.43, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas HLTH's P/E ratio is -0.02. In terms of profitability, CCLDP's ROE is +0.21%, compared to HLTH's ROE of -1.04%. Regarding short-term risk, CCLDP is less volatile compared to HLTH. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs ZCMD Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, ZCMD has a market cap of 5.99M. Regarding current trading prices, CCLDP is priced at $19.43, while ZCMD trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -9.58. In terms of profitability, CCLDP's ROE is +0.21%, compared to ZCMD's ROE of -0.03%. Regarding short-term risk, CCLDP and ZCMD have similar daily volatility (0.00).
CCLDP vs UPH Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, UPH has a market cap of 5.33M. Regarding current trading prices, CCLDP is priced at $19.43, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, CCLDP's ROE is +0.21%, compared to UPH's ROE of -0.54%. Regarding short-term risk, CCLDP is less volatile compared to UPH. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs EUDAW Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, EUDAW has a market cap of 5.20M. Regarding current trading prices, CCLDP is priced at $19.43, while EUDAW trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas EUDAW's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to EUDAW's ROE of +3.05%. Regarding short-term risk, CCLDP is less volatile compared to EUDAW. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs ICCT Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, ICCT has a market cap of 5.08M. Regarding current trading prices, CCLDP is priced at $19.43, while ICCT trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas ICCT's P/E ratio is -0.04. In terms of profitability, CCLDP's ROE is +0.21%, compared to ICCT's ROE of -14.51%. Regarding short-term risk, CCLDP is less volatile compared to ICCT. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs ACON Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, ACON has a market cap of 4.17M. Regarding current trading prices, CCLDP is priced at $19.43, while ACON trades at $7.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas ACON's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to ACON's ROE of -3.67%. Regarding short-term risk, CCLDP is less volatile compared to ACON. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs PEARW Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, PEARW has a market cap of 4.09M. Regarding current trading prices, CCLDP is priced at $19.43, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, CCLDP's ROE is +0.21%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, CCLDP is less volatile compared to PEARW. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs PEAR Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, PEAR has a market cap of 4.09M. Regarding current trading prices, CCLDP is priced at $19.43, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, CCLDP's ROE is +0.21%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, CCLDP is less volatile compared to PEAR. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs FOXO Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, FOXO has a market cap of 2.61M. Regarding current trading prices, CCLDP is priced at $19.43, while FOXO trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas FOXO's P/E ratio is -0.07. In terms of profitability, CCLDP's ROE is +0.21%, compared to FOXO's ROE of -0.01%. Regarding short-term risk, CCLDP is less volatile compared to FOXO. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs CMAX Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, CMAX has a market cap of 1.61M. Regarding current trading prices, CCLDP is priced at $19.43, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, CCLDP's ROE is +0.21%, compared to CMAX's ROE of +30.94%. Regarding short-term risk, CCLDP is less volatile compared to CMAX. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs WGSWW Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, WGSWW has a market cap of 1.42M. Regarding current trading prices, CCLDP is priced at $19.43, while WGSWW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas WGSWW's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to WGSWW's ROE of -0.17%. Regarding short-term risk, CCLDP is less volatile compared to WGSWW. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs LIFWZ Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, LIFWZ has a market cap of 1.25M. Regarding current trading prices, CCLDP is priced at $19.43, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to LIFWZ's ROE of -1.56%. Regarding short-term risk, CCLDP and LIFWZ have similar daily volatility (0.00).
CCLDP vs WORX Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, WORX has a market cap of 1.23M. Regarding current trading prices, CCLDP is priced at $19.43, while WORX trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -0.68. In terms of profitability, CCLDP's ROE is +0.21%, compared to WORX's ROE of -0.28%. Regarding short-term risk, CCLDP is less volatile compared to WORX. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs OTRKP Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, OTRKP has a market cap of 983915.00. Regarding current trading prices, CCLDP is priced at $19.43, while OTRKP trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas OTRKP's P/E ratio is -0.08. In terms of profitability, CCLDP's ROE is +0.21%, compared to OTRKP's ROE of -1.76%. Regarding short-term risk, CCLDP and OTRKP have similar daily volatility (0.00).
CCLDP vs KERNW Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, KERNW has a market cap of 162320.00. Regarding current trading prices, CCLDP is priced at $19.43, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, CCLDP's ROE is +0.21%, compared to KERNW's ROE of -2.22%. Regarding short-term risk, CCLDP is less volatile compared to KERNW. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs KERN Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, KERN has a market cap of 162320.00. Regarding current trading prices, CCLDP is priced at $19.43, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, CCLDP's ROE is +0.21%, compared to KERN's ROE of -2.22%. Regarding short-term risk, CCLDP is less volatile compared to KERN. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs LIFWW Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, LIFWW has a market cap of 60053.00. Regarding current trading prices, CCLDP is priced at $19.43, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to LIFWW's ROE of -1.56%. Regarding short-term risk, CCLDP and LIFWW have similar daily volatility (0.00).
CCLDP vs MSPRZ Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, MSPRZ has a market cap of 47975.00. Regarding current trading prices, CCLDP is priced at $19.43, while MSPRZ trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to MSPRZ's ROE of -1.56%. Regarding short-term risk, CCLDP and MSPRZ have similar daily volatility (0.00).
CCLDP vs CMAXW Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, CMAXW has a market cap of 36386.00. Regarding current trading prices, CCLDP is priced at $19.43, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to CMAXW's ROE of +30.94%. Regarding short-term risk, CCLDP and CMAXW have similar daily volatility (0.00).
CCLDP vs ACONW Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, ACONW has a market cap of 17063.00. Regarding current trading prices, CCLDP is priced at $19.43, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas ACONW's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to ACONW's ROE of -3.67%. Regarding short-term risk, CCLDP and ACONW have similar daily volatility (0.00).
CCLDP vs MSPRW Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, MSPRW has a market cap of 7700.00. Regarding current trading prices, CCLDP is priced at $19.43, while MSPRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas MSPRW's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to MSPRW's ROE of -1.56%. Regarding short-term risk, CCLDP is less volatile compared to MSPRW. This indicates potentially lower risk in terms of short-term price fluctuations for CCLDP.
CCLDP vs UTRS Comparison
CCLDP plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CCLDP stands at 566.58M. In comparison, UTRS has a market cap of 888.00. Regarding current trading prices, CCLDP is priced at $19.43, while UTRS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CCLDP currently has a P/E ratio of N/A, whereas UTRS's P/E ratio is N/A. In terms of profitability, CCLDP's ROE is +0.21%, compared to UTRS's ROE of -1.11%. Regarding short-term risk, CCLDP and UTRS have similar daily volatility (0.00).